Outpatient Prospective Payment System (OPPS) Drug Acquisition Cost Survey
The OPPS Outpatient Drug Acquisition Cost Survey module is now available to collect hospitals’ outpatient drug acquisition cost data. Submitters have until 11:59 p.m. Eastern Standard Time (EST) on March 31, 2026, to enter and submit the required data to CMS. Resources are available in the Related Links section below. For technical assistance with the data collection system, please contact the Help Desk via email at ODACSHelpDesk@dcca.com. For all other questions, please contact OPPSDrugSurvey@cms.hhs.gov.
Overview
On November 25, 2025, CMS issued the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule, which established the OPPS Drug Acquisition Cost Survey (ODACS). CMS published the Final Rule in response to the Executive Order signed by President Trump on April 15, 2025, requiring the Secretary of the Department of Health and Human Services (HHS) to conduct a survey under section 1833(t)(14)(D)(ii) of the Social Security Act to determine the hospital acquisition cost for covered outpatient drugs at hospital outpatient departments. After the survey concludes, the Secretary will consider and propose any necessary adjustments to align Medicare payments with the cost of acquisition, consistent with the budget-neutrality requirement in section 1833(t)(9)(B) of the Social Security Act and other legal requirements.
Questions
For questions, please contact OPPSDrugSurvey@cms.hhs.gov.